These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25246463)

  • 1. Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
    Lam PW; Frost DW
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marihuana and cannobinoids as medicaments].
    Tkaczyk M; Florek E; Piekoszewski W
    Przegl Lek; 2012; 69(10):1095-7. PubMed ID: 23421098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
    Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
    Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum.
    Bonnet U; Specka M; Stratmann U; Ochwadt R; Scherbaum N
    Drug Alcohol Depend; 2014 Oct; 143():189-97. PubMed ID: 25127704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
    Jones SE; Durant JR; Greco FA; Robertone A
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():45-8. PubMed ID: 6299555
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic issues of marijuana and THC (tetrahydrocannabinol).
    Ungerleider JT; Andrysiak T
    Int J Addict; 1985 May; 20(5):691-9. PubMed ID: 2995262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats.
    Parker LA; Mechoulam R; Schlievert C
    Neuroreport; 2002 Apr; 13(5):567-70. PubMed ID: 11973447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
    Levitt M
    Cancer Treat Rev; 1982 Dec; 9 Suppl B():49-53. PubMed ID: 6299556
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy.
    Serafimovska T; Darkovska-Serafimovska M; Stefkov G; Arsova-Sarafinovska Z; Balkanov T
    Folia Med (Plovdiv); 2020 Dec; 62(4):668-678. PubMed ID: 33415919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
    Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The time course and significance of cannabis withdrawal.
    Budney AJ; Moore BA; Vandrey RG; Hughes JR
    J Abnorm Psychol; 2003 Aug; 112(3):393-402. PubMed ID: 12943018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.
    Iacopetti CL; Packer CD
    Clin Med Res; 2014 Sep; 12(1-2):65-7. PubMed ID: 24667219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.